Department of Chemistry, University of Florida, Gainesville, Florida, USA.
J Mass Spectrom. 2023 Jul;58(7):e4958. doi: 10.1002/jms.4958.
Quantification of pharmaceutical compounds using matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS) is an alternative to traditional liquid chromatography (LC)-MS techniques. Benefits of MALDI-based approaches include rapid analysis times for liquid samples and imaging mass spectrometry capabilities for tissue samples. As in most quantification experiments, the use of internal standards can compensate for spot-to-spot and shot-to-shot variability associated with MALDI sampling. However, the lack of chromatographic separation in traditional MALDI analyses results in diminished peak capacity due to the chemical noise background, which can be detrimental to the dynamic range and limit of detection of these approaches. These issues can be mitigated by using a hybrid mass spectrometer equipped with a quadrupole mass filter (QMF) that can be used to fractionate ions based on their mass-to-charge ratios. When the masses of the analytes and internal standards are sufficiently disparate in mass, it can be beneficial to effect multiple narrow mass isolation windows using the QMF, as opposed to a single wide mass isolation window, to minimize chemical noise while allowing for internal standard normalization. Herein, we demonstrate a MALDI MS quantification workflow incorporating multiple sequential mass isolation windows enabled on a QMF, which divides the total number of MALDI laser shots into multiple segments (i.e., one segment for each mass isolation window). This approach is illustrated through the quantitative analysis of the pharmaceutical compound enalapril in human plasma samples as well as the simultaneous quantification of three pharmaceutical compounds (enalapril, ramipril, and verapamil). Results show a decrease in the limit of detection, relative standard deviations below 10%, and accuracy above 85% for drug quantification using multiple mass isolation windows. This approach has also been applied to the quantification of enalapril in brain tissue from a rat dosed in vitro. The average concentration of enalapril determined by imaging mass spectrometry is in agreement with the concentration determined by LC-MS, giving an accuracy of 104%.
使用基质辅助激光解吸/电离(MALDI)质谱(MS)定量药物化合物是传统液相色谱(LC)-MS 技术的替代方法。MALDI 方法的优点包括对液体样品的快速分析时间和对组织样品的成像质谱能力。与大多数定量实验一样,使用内标可以补偿与 MALDI 采样相关的斑点间和射束间变异性。然而,传统 MALDI 分析中缺乏色谱分离会导致由于化学噪声背景而降低峰容量,这会对这些方法的动态范围和检测限产生不利影响。通过使用配备四极质量滤波器(QMF)的混合质谱仪可以减轻这些问题,该 QMF 可以根据质荷比对离子进行分离。当分析物和内标物的质量在质量上足够不同时,使用 QMF 可以有效地实现多个窄质量隔离窗口,而不是单个宽质量隔离窗口,以最小化化学噪声,同时允许内标归一化。在此,我们展示了一种 MALDI MS 定量工作流程,该流程结合了在 QMF 上实现的多个连续质量隔离窗口,该 QMF 将总 MALDI 激光射击次数分为多个部分(即,每个质量隔离窗口一个部分)。通过对人血浆样品中的药物化合物依那普利进行定量分析以及同时对三种药物化合物(依那普利、雷米普利和维拉帕米)进行定量来说明这种方法。结果表明,使用多个质量隔离窗口进行药物定量时,检测限降低,相对标准偏差低于 10%,准确度高于 85%。该方法还应用于体外给药大鼠脑组织中依那普利的定量。通过成像质谱法测定的依那普利的平均浓度与通过 LC-MS 确定的浓度一致,准确度为 104%。